Dexcom (DXCM) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Dexcom (DXCM) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.94 Bn | 194.34 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.49 Bn | 4.50 Bn |
| 3 | Medtronic | 120.01 Bn | 110.79 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.40 Bn | 1.35 Bn |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.02 Bn | 31.91 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.01% |
| Mar 31, 2026 | 28.70% |
| Dec 31, 2025 | -8.26% |
| Sep 30, 2025 | 31.49% |
| Jun 30, 2025 | 31.17% |
| Mar 31, 2025 | 39.57% |
| Dec 31, 2024 | 10.35% |
| Sep 30, 2024 | 24.06% |
| Jun 30, 2024 | 73.38% |
| Mar 31, 2024 | 49.40% |
| Dec 31, 2023 | 27.93% |
| Sep 30, 2023 | 20.97% |
| Jun 30, 2023 | 30.86% |
| Mar 31, 2023 | 32.01% |
| Dec 31, 2022 | 63.73% |
| Sep 30, 2022 | 120.90% |
| Jun 30, 2022 | 77.36% |
| Mar 31, 2022 | 34.08% |
| Dec 31, 2021 | 6.46% |
| Sep 30, 2021 | 46.04% |